Cargando…

SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide

SU4312, initially designed as a multi-target tyrosine kinase inhibitor, is consequently reported to inhibit tumor angiogenesis by blocking VEGFR. However, although SU4312 can penetrate the brain–blood barrier, its potential to inhibit glioma growth is unknown. In this study, we report that SU4312 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xu, Zhou, Yi, Wang, Yan, Wang, Xiang, Zhang, Yu, Mao, Yufei, Zhang, Long, Qi, Ji, Zhang, Yining, Lyu, Feng, Gu, Linbo, Yu, Rutong, Zhou, Xiuping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410026/ https://www.ncbi.nlm.nih.gov/pubmed/36013004 http://dx.doi.org/10.3390/jcm11164765

Ejemplares similares

YAP promotes autophagy and progression of gliomas via upregulating HMGB1
por: Zhao, Min, et al.
Publicado: (2021)

β-catenin-mediated YAP signaling promotes human glioma growth
por: Wang, Yan, et al.
Publicado: (2017)

FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1
por: Wang, Yan, et al.
Publicado: (2022)

Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair
por: Zhang, Yu, et al.
Publicado: (2021)

Interpretation of the LHCb $P_c$(4312)$^+$ Signal
por: Fernández-Ramírez, C., et al.
Publicado: (2019)

Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide
por: Wang, Yan, et al.
Publicado: (2021)

Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas
por: Wang, Xu, et al.
Publicado: (2019)

Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
por: Shi, Hui, et al.
Publicado: (2020)

On the possible virtual state nature of the LHCb Pc$(4312)^+$ signal
por: Silva-Castro, J.A.
Publicado: (2020)

The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
por: Xu, Haoyue, et al.
Publicado: (2022)

Human giant larvae-1 promotes migration and invasion of malignant glioma cells by regulating N-cadherin
por: Wang, Yan, et al.
Publicado: (2021)

Screening and identification of LMNB1 and DLGAP5, two key biomarkers in gliomas
por: Zhou, Ding, et al.
Publicado: (2021)

Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop
por: Wang, Yan, et al.
Publicado: (2023)

Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
por: Zhang, Xin, et al.
Publicado: (2018)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

Isolation, cultivation and identification of brain glioma stem cells by magnetic bead sorting☆
por: Zhou, Xiuping, et al.
Publicado: (2012)

Observation of a narrow pentaquark state, $P_c(4312)^+$, and of two-peak structure of the $P_c(4450)^+$
por: Aaij, Roel, et al.
Publicado: (2019)

AS602801 sensitizes glioma cells to temozolomide and vincristine by blocking gap junction communication between glioma cells and astrocytes
por: Zhang, Shuai, et al.
Publicado: (2021)

PSMG3‐AS1 enhances glioma resistance to temozolomide via stabilizing c‐Myc in the nucleus
por: Zhou, Li, et al.
Publicado: (2022)

Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas
por: Gu, Qiang, et al.
Publicado: (2023)

BAG3 regulates stability of IL-8 mRNA via interplay between HuR and miR-4312 in PDACs
por: Li, Chao, et al.
Publicado: (2018)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7
por: Liu, Zhi-Qin, et al.
Publicado: (2020)

Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide
por: Ding, Yiming, et al.
Publicado: (2021)

Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016)

Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
por: Hou, Xiaoying, et al.
Publicado: (2023)

Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway
por: Ye, Tingting, et al.
Publicado: (2022)

NEDD4-1 Regulates Migration and Invasion of Glioma Cells through CNrasGEF Ubiquitination In Vitro
por: Zhang, Hao, et al.
Publicado: (2013)

CUL4B Promotes Temozolomide Resistance in Gliomas by Epigenetically Repressing CDNK1A Transcription
por: Ye, Xiang, et al.
Publicado: (2021)

LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma
por: Chen, Wei-Lin, et al.
Publicado: (2019)

AEG-1 silencing attenuates M2-polarization of glioma-associated microglia/macrophages and sensitizes glioma cells to temozolomide
por: Li, Jing, et al.
Publicado: (2021)

Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide
por: Li, Tengfei, et al.
Publicado: (2020)

Intelligent Nanoparticles With pH-Sensitive Co-Delivery of Temozolomide and siEGFR to Ameliorate Glioma Therapy
por: Wang, Zhen, et al.
Publicado: (2022)

DIPG-26. THERAPEUTIC EFFECTS OF RADIOTHERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE VERSUS RADIOTHERAPY WITH CONCOMITANT TEMOZOLOMIDE ALONE IN CHILDREN WITH DIPG: A SINGLE-CENTER EXPERIENCE WITH 82 CASES
por: Lai, Mingyao, et al.
Publicado: (2020)

miR-9-5p Mediates ABCC1 to Elevate the Sensitivity of Glioma Cells to Temozolomide
por: Chen, Xiang-Rui, et al.
Publicado: (2021)

Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway
por: Gao, Shangfeng, et al.
Publicado: (2017)

Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant glioma
por: Yuan, Qiuyun, et al.
Publicado: (2021)

Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo
por: Yu, Zhiyun, et al.
Publicado: (2015)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
por: ABE, Hideaki, et al.
Publicado: (2018)

Inhibition of Elongation Factor-2 Kinase Augments the Antitumor Activity of Temozolomide against Glioma
por: Liu, Xiao-yuan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qk5j8ge9v61u2vqkph3jjnc3rs